Clinical Trial: A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875934) titled 'A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis' on March 09.

Brief Summary: The objective of this study is to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of SHR-1139 injection in patients with moderate to severe plaque psoriasis.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Plaque Psoriasis

Intervention: DRUG: SHR-1139 Injection

SHR-1139 injection.

DRUG: SHR-1139 Injection Placebo

SHR-1139 injection placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd...